Non-White MS Patients Rarely Included in Trials
Over 25 years of clinical research, phase 3 trials of approved disease-modifying therapies for multiple sclerosis were overwhelmingly made up of White participants, new research shows.
Medscape Medical News
source https://www.medscape.com/viewarticle/975158?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/975158?src=rss
Comments
Post a Comment